Shares outstanding increased 88.8%
Shares outstanding changed +88.8% from the comparable as-filed period. The change ranks at the 71th percentile of 7 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed +88.8% from the comparable as-filed period. The change ranks at the 71th percentile of 7 prior comparable changes.
Research & development changed +29.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Stock-based compensation changed -96.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Current liabilities changed +43.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating cash flow changed +10.0% from the comparable as-filed period.
Current ratio changed -29.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating income changed +6.8% from the comparable as-filed period.
Working capital / assets changed -221 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Working capital changed -1.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Total assets changed +1.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Current assets changed +1.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Stock-based compensation changed -88.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Shares outstanding changed +53.5% from the comparable as-filed period. The change ranks at the 57th percentile of 7 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Research & development changed +61.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Working capital / assets changed -574 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Total assets changed -36.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Working capital changed -40.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Current assets changed -36.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Current ratio changed -49.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Operating cash flow changed -13.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Operating income changed -8.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Current liabilities changed +26.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.